Last update 11 Dec 2024

Umbilical cord derived mesenchymal stem cells(Wuhan Union Hospital)

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms
UC-MSCs(Wuhan Union Hospital)
Target-
Mechanism
Stem cell replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesInfectious Diseases+ [2]
Active Indication
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnemia+ [5]
Inactive Indication-
Originator Organization
Wuhan Xiehe Hospital Tower
Active Organization
Wuhan Xiehe Hospital Tower
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Umbilical cord derived mesenchymal stem cells(Wuhan Union Hospital)
NCT05672420 / Not yet recruitingPhase 1/2IIT
A Multicenter, Phase Ib/II Trial of the Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cells in Treatment-induced Myelosuppression in Patients With Hematologic Malignancies (USMYE Trial)
100 Clinical Results associated with Umbilical cord derived mesenchymal stem cells(Wuhan Union Hospital)
Login to view more data
100 Translational Medicine associated with Umbilical cord derived mesenchymal stem cells(Wuhan Union Hospital)
Login to view more data
100 Patents (Medical) associated with Umbilical cord derived mesenchymal stem cells(Wuhan Union Hospital)
Login to view more data
100 Deals associated with Umbilical cord derived mesenchymal stem cells(Wuhan Union Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Lymphoblastic LeukemiaPhase 2
CN
Wuhan Xiehe Hospital Tower
01 Jan 2023
Acute Myeloid LeukemiaPhase 2
CN
Wuhan Xiehe Hospital Tower
01 Jan 2023
AnemiaPhase 2
CN
Wuhan Xiehe Hospital Tower
01 Jan 2023
Bone marrow depressionPhase 2
CN
Wuhan Xiehe Hospital Tower
01 Jan 2023
HemorrhagePhase 2
CN
Wuhan Xiehe Hospital Tower
01 Jan 2023
Infectious DiseasesPhase 2
CN
Wuhan Xiehe Hospital Tower
01 Jan 2023
NeutropeniaPhase 2
CN
Wuhan Xiehe Hospital Tower
01 Jan 2023
ThrombocytopeniaPhase 2
CN
Wuhan Xiehe Hospital Tower
01 Jan 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free